BAUDRY PASTILLES Lozenges B/70g

Aconitum napellus 5 CH.......................................................................................................................... 1,42 mg

Belladonna 5 CH....................................................................................................................................... 1,42 mg

Bryonia 5 CH.............................................................................................................................................. 1,42 mg

Coccus cacti 5 CH.................................................................................................................................... 1,42 mg

Drosera 5 CH............................................................................................................................................. 1,42 mg

Ipeca 5 CH................................................................................................................................................. 1,42 mg

For a lozenge of 1 g.

Excipients with known effect: Sucrose, glucose, sorbitol (E420), red colouring Ponceau 4R (E124), propylene glycol (E1520).

One lozenge contains 223,5 mg of sucrose, 131,2 mg of glucose, 68 mg of sorbitol, 0,085 mg of red colouring Ponceau 4R (E124) and 3,7 mg of propylene glycol.

Homeopathic medicine traditionally used for the symptomatic treatment of cough.

Reserved for adults and children from 6 years of age.

Dosage

Adults: 6 to 12 lozenges, at most, per day.

Children from 6 years of age: 6 lozenges, at most, per day.

Space out doses according to improvement.

The duration of treatment must not exceed one week.

An absence of improvement after 3 days should lead to consulting a doctor.

Method of administration

Oral use.

Children under 6 years.

Hypersensitivity to the active substances or to any of the excipients listed in section Composition.

This medicine contains 68 mg of sorbitol per lozenge. The additive effect of concomitantly administered products containing fructose (or sorbitol) and the dietary intake of fructose (or sorbitol) must be taken into account. The sorbitol content of oral medicines may affect the bioavailability of other concomitantly administered oral medicines.

Patients with hereditary fructose intolerance (HFI) must not take this medicine.

This medicine contains 3,7 mg of propylene glycol per lozenge.

This medicine contains glucose. Its use is not recommended in patients with glucose-galactose malabsorption syndrome.

This medicine contains sucrose. Patients with fructose intolerance, glucose-galactose malabsorption syndrome or sucrase/isomaltase deficiency (rare hereditary diseases) must not take this medicine.

This medicine contains an azo colouring agent (E124) and may cause allergic reactions.

Given the dilution level of the strains and despite the absence of sufficient experimental and clinical data, PÂTES BAUDRY, pâte à sucer may be used in pregnant or breastfeeding women.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reaction via the national reporting system: National Agency for the Safety of Medicines and Health Products (ANSM) and the network of Regional Centres of Pharmacovigilance - Website: www.signalement-sante.gouv.fr..

Pharmacotherapeutic class: Homeopathic medicine.

In the absence of scientific data, the indication of this medicine is based on the traditional homeopathic use of its components.

3 years.

No special precautions for storage.

No special requirements.